Hsa-miR-218靶向調(diào)控LASP1對(duì)宮頸癌HeLa細(xì)胞生長(zhǎng)的影響
[Abstract]:Objective: to investigate the effect of human minimal RNA-218 (Homo sapiens microRNA-218,hsa-miR-218 on the growth of cervical cancer HeLa cells and its molecular mechanism. Methods: the recombinant lentivirus expression vector pmiR-218, of hsa-miR-218 was constructed and pmiR-218 was infected into HeLa cells. Trypan blue exclusion assay was used to detect cell number and WST-8 method was used to detect cell viability. The luciferase reporter gene vector was constructed to verify the interaction of miR-218 with LIM and SH3 protein 1 (LASP1). The mRNA relative expression level of LASP1 was detected by real-time PCR and the expression level of LASP1 protein was detected by, Western blot. Results: the results of DNA sequencing showed that the recombinant lentivirus expression vector pmiR-218.pmiR-218 was successfully constructed, and the survival number of HeLa cells was 176 鹵9 after 72 h transfection. There was a time-effect relationship on the inhibition rate of HeLa cell viability, compared with the blank control group, the difference was significant (P0.05). The results of luciferase activity showed that the plasmids of LASP1-3'UTR cloned into 293T cells were cotransfected with miR-218 mimics, which resulted in the decrease of luciferase activity, and real-time PCR showed that the expression level of miR-218 increased after transfection of pmiR-218. Overexpression of miR-128 could down-regulate the relative expression of LASP1 mRNA and protein, compared with the control group and negative control group, the difference was significant (P0.01). Conclusion: pmiR-218 can effectively inhibit the growth of HeLa cells and has a time-effect relationship. The mechanism may be that miR-218 can down-regulate the expression of miR-218 in HeLa cells by targeting LASP1.
【作者單位】: 吉安市婦幼保健院婦產(chǎn)科;廣州市南吉生物技術(shù)有限公司;廣州市番禺區(qū)中心醫(yī)院檢驗(yàn)科;
【基金】:廣州市番禺區(qū)科技局珠江科技新星項(xiàng)目(No.2013-專-15-6.09)
【分類號(hào)】:R737.33
【參考文獻(xiàn)】
相關(guān)期刊論文 前5條
1 朱耀魁;程妮;胡穎;岑穎洲;;微RNA在宮頸癌發(fā)生發(fā)展中作用及其與HPV相互關(guān)系[J];生理科學(xué)進(jìn)展;2012年04期
2 陳軍瑩;姚德生;賀嬋娟;盧艷;歐婷瑜;;宮頸鱗癌MicroRNA差異表達(dá)的研究[J];實(shí)用醫(yī)學(xué)雜志;2014年01期
3 祁軍安;梁容瑞;李宗芳;張澍;江奎;黃辰;楊軍;;Lasp-1蛋白在肝癌組織中表達(dá)及臨床意義[J];西部醫(yī)學(xué);2013年10期
4 靳有鵬;龐婷婷;王偉;王玉林;;人肺動(dòng)脈平滑肌細(xì)胞中微小RNA-210通過MKP-1負(fù)性調(diào)節(jié)低氧下細(xì)胞的增殖[J];中國病理生理雜志;2014年11期
5 Kangkang Zeng;Wei Zhang;Xiaoxia Hu;;miR-218與宮頸癌關(guān)系的研究進(jìn)展(英文)[J];The Chinese-German Journal of Clinical Oncology;2013年08期
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 袁泉;柳滿然;曾宗躍;周旭春;;microRNA與胃癌耐藥的關(guān)系[J];國際檢驗(yàn)醫(yī)學(xué)雜志;2013年17期
2 Patrick-Denis St-Coeur;Mohamed Touaibia;Miroslava Cuperlovic-Culf;Pier Jr Morin;;Leveraging Metabolomics to Assess the Next Generation of Temozolomide-based Therapeutic Approaches for Glioblastomas[J];Genomics, Proteomics & Bioinformatics;2013年04期
3 楊先濤;張禎禎;詹學(xué);朱朝敏;;肺結(jié)核患兒外周血單個(gè)核細(xì)胞中microRNA表達(dá)的初步研究[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2013年19期
4 Wenwen Jia;Wen Chen;Jiuhong Kang;;The Functions of MicroRNAs and Long Non-coding RNAs in Embryonic and Induced Pluripotent Stem Cells[J];Genomics,Proteomics & Bioinformatics;2013年05期
5 林松;范磊;邵增務(wù);;微RNA調(diào)控自噬研究進(jìn)展[J];國際骨科學(xué)雜志;2013年05期
6 張世芳;魏彩虹;陸健;張小寧;周鑫磊;張淑珍;王光凱;曹家雪;趙福平;張莉;杜立新;;深度測(cè)序鑒定綿羊microRNA轉(zhuǎn)錄組[J];中國畜牧獸醫(yī);2013年09期
7 葉辛;張蕾;石磊;谷明莉;張薇薇;張建榮;秦琴;錢寶華;鄧安梅;;免疫性血小板減少性紫癜患者單個(gè)核細(xì)胞中microRNA-30a表達(dá)增高及其意義[J];國際檢驗(yàn)醫(yī)學(xué)雜志;2013年24期
8 Hong Zheng;Jia-Yu Liu;Feng-Ju Song;Ke-Xin Chen;;Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer[J];Cancer Biology & Medicine;2013年03期
9 徐t,
本文編號(hào):2339155
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/2339155.html